Furthermore, serine-threonine protein kinase (Akt), an upstream regulator of GSK3β, could facilitate GSK3β phosphorylation to inhibit GSK3β activity and thus has been implicated in modulating depression and other neuropsychopathies (Wang et al., 2021). Here, GSK3B is linked to depressive symptom measurement.